Phase II Study of Combined Modality Treatment in Primary Testicular Non-Hodgkin's Lymphoma

Clinical trial NCT00210379 · COMPLETED

Trial details

NCT number: NCT00210379
Sponsor: International Extranodal Lymphoma Study Group (IELSG)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma, B Cell

Start date: 2000-11-01
Primary completion: 2004-11-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.